Status:
UNKNOWN
Does Pulmonary Daoyin of China Give Additional Benefit Over Usual Therapy in Management of Stable Chronic Obstructive Pulmonary Disease?
Lead Sponsor:
Henan University of Traditional Chinese Medicine
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
40-80 years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the exercise capacity and pulmonary function test parameters of Chronic Obstructive Pulmonary Disease (COPD) patients who underwent usual care with and without ...
Detailed Description
This is a multicenter, randomized, none-blind, controlled study to evaluate the effect of pulmonary daoyin therapy in moderate to very severe COPD subjects. Following a 14 day run-in period, approxima...
Eligibility Criteria
Inclusion
- A confirmed diagnosis of moderate to very severe COPD.
- Age between 40 and 80 years.
- Without participation in other interventional trials in the previous one month.
- With the informed consent signed.
Exclusion
- Patients with poor mobility that can not do the exercise, i.e. wheelchair bound.
- Pregnant or breast-feeding women.
- Resting pulmonary artery pressure \> 45mmHg.
- Any psychiatric condition rendering the patient unable to understand the nature, scope and possible consequences of the study.
- Patients with severe comorbidities, including acute myocardial infarction and unstable angina pectoris.
- Patients with post exercise syncope and osteoarthrosis that affect movement.
- Complicated with severe heart failure (class II to IV NYHA heart function).
- Complicated with bronchial asthma, bronchiectasis or active tuberculosis;
- Complicated with obliterative bronchiolitis or diffuse pantothenic bronchiolitis，
- Complicated with pneumothorax, pleural effusion or pulmonary embolism.
- Complicated with neuromuscular disorder which affects the respiration.
- Complicated with tumors .
- Complicated with serious hepatic and renal diseases.
- Long periods of bed rest .
- Participating in other trials or allergic to the used medicine.
Key Trial Info
Start Date :
November 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2013
Estimated Enrollment :
464 Patients enrolled
Trial Details
Trial ID
NCT01482000
Start Date
November 1 2011
End Date
December 1 2013
Last Update
November 30 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.